Researchers in the United Kingdom have uncovered a mechanism by which fast-growing bacteria resists treatment by antibiotics. The findings, published recently in the journal e-Life, could be used to inform the development of improved antibiotic compounds that target this survival strategy.

“Antibiotic resistance continues to threaten the viability of current treatments. We need to understand how individual bacteria within a colony can prevent antibiotics from entering their cells, so that we can target this mechanism with new therapies,” says Urszula Łapińska, a post-doctoral research assistant at the University of Exeter. 

Search Antibodies
Search Now Use our Antibody Search Tool to find the right antibody for your research. Filter
by Type, Application, Reactivity, Host, Clonality, Conjugate/Tag, and Isotype.

Łapińska and colleagues began with the hypothesis that variations in how bacteria respond to drugs could be driven by the varying drug transport rates between individual cells. “Most existing data around drug permeability in bacteria has been attained through measurements that either take an average result from a large population or are derived from a small number of bacteria,” Łapińska says. “This means that little is known about the variability in individual drug accumulation across many single cells in a bacterial colony.”

To test their hypothesis, the team used a multi-analytical approach, combining microfluidics-microscopy, several bacteria that pose significant health threats, and fluorescent probes derived from antibiotics.

The approach allowed the team to examine the interactions between commonplace antibiotics and many live, individual bacteria in real-time, during drug dosage. By combining this approach with mathematical modelling techniques, the team obtained data that they could use to quickly and efficiently identify individual bacteria that are antibiotic resistant.

The results show that fast-growing individuals within bacterial colonies display a significantly higher expression of active ribosomes, which are particles within the cell that synthesize proteins. Ribosomes also enable essential cellular processes, including efflux, a system that pumps toxic substances, such as antimicrobial compounds, out of the cell. This higher expression of ribosomes therefore helps the bacteria avoid the accumulation of macrolides, an important class of antibiotics.

Using this new knowledge, the researchers then showed that chemically manipulating the outer membrane of the bacterial cells allows to eradicate fast-growing variants that exhibit low macrolide accumulation, therefore aiding our fight against antibiotic resistance.

“This work reveals a hitherto unrecognized survival strategy in some members of bacterial colonies ,” says Dr. Stefano Pagliara, Senior Lecturer in Microfluidics at the University of Exeter. “These insights will directly benefit microbiologists and clinicians who are working on the development of more effective antibiotic therapies. In the longer term, we hope that using our novel approach in clinical settings will help inform the design of improved drugs and help us in the fight against antibiotic resistance.”